Peter Fang is the Worldwide Vice President, Neuroscience Global Commercial Strategy Organization for Johnson & Johnson. Working closely with Research & Development, he is responsible for developing and driving commercial strategies for the Neuroscience portfolio and pipeline within neuropsychiatric, neurodegenerative and autoantibody-driven diseases of the nervous system. Peter oversees Strategic Marketing, Market Access, Medical Affairs and Strategic Analytics teams that support the Global Neuroscience business.
Prior to Johnson & Johnson, Peter was Senior Vice President, Head of the U.S. Specialty Care Franchise at Boehringer Ingelheim (BI), where he was responsible for a portfolio of therapies across Interstitial Lung Diseases, Oncology, Dermatology, Biosimilars and Mental Health. Peter joined BI as Senior Vice President, Global Therapeutic Area Head Inflammation, where he led global therapeutic area strategy and developed, launched, and drove both R&D and commercial strategies for a broad portfolio of therapies in Immunology and Pulmonary Fibrosis.
Previously, Peter held multiple senior leadership positions at Baxter, Baxalta, Shire and Takeda, where he was directly responsible for businesses in the U.S., Europe, Middle East, Africa, Asia Pacific, and China. He also has been a leader in Global, Regional and International Marketing roles, where he launched and drove commercial development of products in Hematology, Immunology and Devices and Digital Therapeutics.
Peter began his career, working in venture capital, strategy, and business development roles in technology. He holds a degree in Economics from the Wharton School of the University of Pennsylvania.